Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ascend Vitality vs bmiMD

By GLP-1 ScorecardUpdated

Ascend VitalityFactor scores not reassessed.
Site position #333

Lower score

bmiMDFactor scores not reassessed.
Site position #27

Higher score

Score comparison

bmiMD has the higher recorded score — 79.2/100 to 60.9/100.

bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Before you choose

Before comparing the headline prices, the Ascend Vitality review and the bmiMD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Ascend Vitality vs CoreAge Rx and bmiMD vs CoreAge Rx compare each of them with another graded program, and the list of alternatives to Ascend Vitality ranks the programs closest to Ascend Vitality on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuebmiMD +38
50
88
Dose & formulationbmiMD +7
75
82
Clinical oversightAscend Vitality +4
74
70
Labs & monitoringbmiMD +20
52
72
FulfillmentbmiMD +19
65
84
Contract termsbmiMD +37
37
74
Ascend Vitality · top barbmiMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAscend VitalitybmiMD
WeighScore60.9/10079.2/100
GradeCC+
Site position#333#27
SemaglutideAs low as $89/mo (clinician, medication and shipping included; plan length unpublished, compounded)$129/mo on the one-month plan ($99/mo equivalent with $1,188 prepaid for 12 months)
TirzepatideAs low as $119/mo (clinician, medication and shipping included; plan length unpublished, compounded)$179/mo on the one-month plan ($139/mo equivalent with $1,668 prepaid for 12 months)
CoverageCoverage not confirmed for the selected planAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Ascend Vitality

Site position #333 · C

Factor scores not reassessed.

Strengths

  • Publishes separate injection offers and lists oral semaglutide
  • Treatment pages say the clinician visit, medication and shipping are included, and you pay only if prescribed

What to consider

  • “As low as” rates do not say which plan length, dose or upfront charge they require
  • Terms require cancellation at least five business days before the next scheduled charge
bmiMD

Site position #27 · C+

Factor scores not reassessed.

Strengths

  • Advertises the same price across prescribed doses for each selected injection plan
  • Publishes compounded semaglutide and tirzepatide injection plans
  • Every rung of both ladders is published with the total charge beside each per-month figure
  • All 50 states

What to consider

  • The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
  • The annual $99 and $139 monthly equivalents require $1,188 or $1,668 paid upfront for 12 months
  • A higher $229 and $349 monthly figure is printed beside every plan price under a standing LIMITED TIME label, with no published basis
  • Neither the compounding pharmacy nor the prescribing group is named on the product pages

Featured provider

bmiMD

Factor scores not reassessed.

bmiMD scores 79.2/100 (C+). bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard